Aramune
Belfast, GB · 5 known investors
Find your way into Aramune
Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions. The company builds on molecular nutrition research to create treatments for the healthcare market.
Founders & leadership
B
BrianProfessor of Molecular Nutrition
CN
Chris Nicklin
Board
S
Stuart
Investors · 5
Also in the syndicate · 3
Co-Fund NIleadQUBIS Innovation FundSapphire Capital Partners
Funding
SEC filings, press & company announcements- Undisclosed amountseedMay 2022 · 2 sources
Co-Fund NI (lead), QUBIS (lead), Clarendon Fund Managers, QUBIS Innovation Fund, Sapphire Capital Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aramune do?
- Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions. The company builds on molecular nutrition research to create treatments for the healthcare market.
- Who founded Aramune?
- Aramune was founded by Brian, Chris Nicklin.
- Who are Aramune's investors?
- Aramune's investors include Clarendon Fund Managers Ltd., QUBIS.
- Where is Aramune headquartered?
- Aramune is headquartered in Belfast, GB.